Last reviewed · How we verify
hyaluronic acid and chondroitin sulphate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
hyaluronic acid and chondroitin sulphate (hyaluronic acid and chondroitin sulphate) — Samsung Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| hyaluronic acid and chondroitin sulphate TARGET | hyaluronic acid and chondroitin sulphate | Samsung Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- hyaluronic acid and chondroitin sulphate CI watch — RSS
- hyaluronic acid and chondroitin sulphate CI watch — Atom
- hyaluronic acid and chondroitin sulphate CI watch — JSON
- hyaluronic acid and chondroitin sulphate alone — RSS
Cite this brief
Drug Landscape (2026). hyaluronic acid and chondroitin sulphate — Competitive Intelligence Brief. https://druglandscape.com/ci/hyaluronic-acid-and-chondroitin-sulphate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab